nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Risperidone—ABCB1—adrenal gland cancer	0.00937	1	CrCbGaD
Paliperidone—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000386	0.00039	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000385	0.000389	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000385	0.000389	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000384	0.000388	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000381	0.000385	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000379	0.000383	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000375	0.000379	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CDC42—adrenal gland cancer	0.000375	0.000378	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000375	0.000378	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000372	0.000375	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000369	0.000372	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000368	0.000371	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000367	0.000371	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000364	0.000367	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000363	0.000366	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000363	0.000366	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	0.000361	0.000365	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000361	0.000364	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	0.000358	0.000362	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000355	0.000358	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000354	0.000358	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000352	0.000356	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000349	0.000353	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000348	0.000351	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000346	0.00035	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000342	0.000345	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.00034	0.000344	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000337	0.000341	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000337	0.00034	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000333	0.000336	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000331	0.000335	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000331	0.000334	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000327	0.00033	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000326	0.000329	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000325	0.000328	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000322	0.000326	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000322	0.000325	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000321	0.000324	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000321	0.000324	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000318	0.000321	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000316	0.000319	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000315	0.000318	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000314	0.000317	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000314	0.000317	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000312	0.000315	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.00031	0.000313	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000306	0.000309	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000306	0.000308	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000306	0.000308	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000301	0.000304	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000301	0.000304	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000301	0.000304	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000301	0.000303	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.0003	0.000303	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.0003	0.000303	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000296	0.000298	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000295	0.000298	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000295	0.000297	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000294	0.000297	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.00029	0.000293	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.00029	0.000292	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000289	0.000292	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000289	0.000291	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000287	0.00029	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000287	0.00029	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000281	0.000283	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00028	0.000283	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00028	0.000282	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000278	0.000281	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000277	0.00028	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000277	0.00028	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000276	0.000279	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000276	0.000278	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000274	0.000276	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000273	0.000276	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000272	0.000275	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000272	0.000274	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000271	0.000273	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000271	0.000273	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000271	0.000273	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00027	0.000273	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000269	0.000272	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000269	0.000271	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000268	0.000271	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000267	0.00027	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000267	0.00027	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000266	0.000269	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000266	0.000268	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000264	0.000267	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000262	0.000264	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.000262	0.000264	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000261	0.000263	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000258	0.00026	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000256	0.000258	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000255	0.000257	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000253	0.000255	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000252	0.000254	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000252	0.000254	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000251	0.000253	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.00025	0.000253	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.00025	0.000253	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000248	0.000251	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000247	0.00025	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000246	0.000248	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000245	0.000248	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000245	0.000247	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000243	0.000246	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000242	0.000244	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000242	0.000244	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000241	0.000243	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000241	0.000243	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000241	0.000243	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.00024	0.000242	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.00024	0.000242	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000239	0.000241	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000239	0.000241	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000238	0.00024	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000237	0.00024	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000237	0.000239	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000236	0.000238	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000235	0.000237	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000235	0.000237	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000234	0.000237	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000234	0.000236	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000233	0.000235	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000233	0.000235	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000232	0.000235	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000232	0.000234	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000231	0.000233	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000229	0.000231	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000228	0.00023	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000225	0.000227	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000222	0.000224	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.00022	0.000222	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000218	0.00022	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000217	0.000219	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000216	0.000218	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000214	0.000216	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000214	0.000216	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000213	0.000215	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000212	0.000214	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.00021	0.000212	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.00021	0.000212	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000208	0.00021	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000205	0.000207	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000205	0.000207	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000204	0.000206	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000203	0.000204	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000201	0.000203	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000201	0.000203	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000201	0.000203	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000197	0.000199	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000196	0.000198	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000193	0.000195	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000193	0.000195	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000191	0.000193	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000188	0.00019	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000187	0.000188	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000186	0.000187	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000185	0.000187	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000184	0.000186	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000183	0.000185	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000183	0.000185	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000181	0.000182	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000179	0.00018	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000179	0.00018	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000178	0.00018	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000178	0.000179	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000178	0.000179	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000178	0.000179	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000176	0.000177	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000175	0.000177	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000175	0.000177	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000175	0.000177	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000175	0.000176	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000173	0.000175	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000172	0.000174	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000172	0.000174	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000171	0.000173	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00017	0.000172	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.00017	0.000171	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000167	0.000168	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000164	0.000165	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000162	0.000163	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000161	0.000163	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000161	0.000162	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000161	0.000162	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000159	0.000161	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000159	0.000161	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000159	0.00016	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000158	0.000159	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000157	0.000158	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000156	0.000157	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000155	0.000156	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000154	0.000156	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000154	0.000156	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000153	0.000154	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000151	0.000153	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000147	0.000148	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000145	0.000146	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000142	0.000143	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00014	0.000142	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.00014	0.000141	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000139	0.00014	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000138	0.000139	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000137	0.000138	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	0.000136	0.000138	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000133	0.000135	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000133	0.000134	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000129	0.00013	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000128	0.000129	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000127	0.000128	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000123	0.000124	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	0.000121	0.000122	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000119	0.00012	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000117	0.000118	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000116	0.000117	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000115	0.000116	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000115	0.000116	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—adrenal gland cancer	0.000114	0.000116	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000114	0.000115	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000113	0.000114	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000111	0.000112	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000109	0.00011	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000109	0.00011	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000106	0.000107	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000105	0.000106	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000105	0.000106	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000103	0.000104	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000102	0.000103	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—adrenal gland cancer	0.000102	0.000103	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000101	0.000101	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	9.27e-05	9.36e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	9.18e-05	9.27e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.12e-05	9.21e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.12e-05	9.21e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	9.1e-05	9.19e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	8.93e-05	9.01e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	8.86e-05	8.95e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	8.82e-05	8.9e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	8.58e-05	8.66e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	8.44e-05	8.52e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	8.3e-05	8.38e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—adrenal gland cancer	7.78e-05	7.86e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	7.66e-05	7.73e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—adrenal gland cancer	7.64e-05	7.71e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	7.5e-05	7.57e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.48e-05	7.55e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	6.97e-05	7.03e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.96e-05	6.02e-05	CbGpPWpGaD
